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Abstract
A previously undetected retrovirus has been isolated from the human Epstein–Barr virus (EBV)-negative, B-lymphoblastoid DG-75 cell
line, widely used for EBV gene transfection studies. The complete 8207-base genome of the DG-75 retrovirus was molecularly cloned from
viral mRNA and sequenced (Accession No. AF221065). Northern blot analysis with probes specific for the putative RU-5, gag, pol, and
env regions identified a full-length viral RNA and spliced env mRNA. DG-75 viral RNA was isolated from the DG-75 cell sublines UW
and KAR, but not from the HAD subline. The DG-75 retrovirus was isolated with primer-binding sites that match tRNAThr and tRNAGln2.
Homology searches revealed homology to (i) xenotropic NZB-9-1 env mRNA, (ii) Moloney-MLV pol region, and (iii) a truncated Evi-2
endogenous proviral sequence gag and pol region. Viral interference and infectivity assays confirmed the xenotropic nature of the DG-75
retrovirus. The DG-75 retrovirus is the first isolate of an exogenous xenotropic MLV in which the full-length genomic sequence has been
characterized.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The murine leukemia viruses (MLVs) comprise a group
of C-type retroviruses that can produce leukemia, lym-
phoma, and neurologic disease in rodents. They are classi-
fied into four major host range subgroups based on the
distribution of their cell-surface receptors among mamma-
lian species and accordingly their ability to infect such
species (Cunningham and Kim, 1994; Goff, 2001; Hunter,
1997). The receptor for ecotropic MLV strains, which are
infectious for mice and rats, is restricted to cells of rodent
origin. The receptor for xenotropic viruses is present on
cells of a variety of species, but not on mouse cells, al-
though xenotropic viruses are weakly infectious for feral
mice. The amphotropic and dual or polytropic viruses uti-
lize receptors found on the cells both of rodents and of other
mammalian species. These different groups can be further
identified by the use of viral interference assays (Weiss,
1993), which measure the inhibition of superinfection that
depends on the interaction between the viral envelope (Env)
proteins and the cell receptor. Xenotropic and polytropic
MLVs are present as endogenous proviruses in inbred
strains of mice, whereas amphotropic viruses are exogenous
MLVs that can efficiently infect human cells (Hunter,
1997).
The receptor for both polytropic and xenotropic MLVs
has been cloned from cDNA libraries of human lympho-
cytes, human epithelial cells (HeLa), and murine NIH3T3
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fibroblasts (Battini et al., 1999; Tailor et al., 1999; Yang et
al., 1999). The ecotropic MLV receptor was identified as the
murine cationic amino acid transporter CAT-1, which be-
longs to a family of multiple, membrane-spanning, solute
transporters (Albritton et al., 1989). A related family mem-
ber, sodium phosphate symporter (Pit1), previously identi-
fied as the receptor for gibbon ape leukemia virus and feline
leukemia virus subgroub B, is used by the distinctive MLV-
10A1 (Miller and Miller, 1994; Wilson et al., 1994); this
virus can also use a structurally and functionally related
receptor for amphotropic MLV, the sodium-dependant
phosphate symporter Pit2 (Sommerfelt, 1999; van Zeijl et
al., 1994).
A previously unrecognized C-type retrovirus, which is
constitutively produced and released by two sublines of
Epstein–Barr virus (EBV)-negative, human B-lymphoblas-
toid DG-75 cells, widely used for EBV gene transfection
studies (Fahraeus et al., 1990; Harada and Yanagi, 1992),
was identified immunologically as MLV (Raisch et al.,
1998). This DG-75 MLV was infectious for a third DG-75
subline designated Hadassah (HAD) (Ben-Bassat et al.,
1977). The HAD subline was originally shown to be retro-
virus-free by RT-PCR (Raisch et al., 1998).
In this study, the DG-75 retrovirus was characterized by
molecular cloning and sequencing of its entire 8207-base
genome. The env gene of the DG-75 retrovirus has homol-
ogy to the xenotropic NZB-9-1 proviral sequence (O’Neill
et al., 1985), and its gag gene has homology to that of the
defective Evi-2 provirus, which is integrated at the Evi-2
(ecotropic viral integration site-2) locus in the tumor-sup-
pressor neurofibromatosis type I gene (Cho et al., 1995).
The initial 1490-nucleotide (nt) portion of the pol region has
high homology to Moloney MLV, whereas the final 1765-nt
section has high homology to the truncated Evi-2 endoge-
nous proviral sequence. Two primer-binding sites (PBS)
have been identified for the DG-75 retrovirus clones. One
PBS uses glutamine-2 tRNA, and the second PBS uses
threonine tRNA, which corresponds to the PBS for the
Evi-2 provirus. Two DG-75 viral mRNA molecules were
identified, one full-length of about 8.2 kb and another for
the spliced env mRNA of 2.9 kb. The viral mRNAs were
found associated with the two constitutively productive sub-
lines, KAR and UW, whereas the HAD subline had none.
The inability of DG-75 virus to infect murine cells and its
infectivity for other mammalian species cells, especially
some human cells, indicate its xenotropic nature, which was
confirmed by retroviral interference assays.
Results
Genomic structure of DG-75 viral RNA
Five overlapping cDNA fragments of the DG-75 genome
were cloned. Multiple clones for each cDNA fragment were
sequenced in both directions and aligned to determine the
complete genomic sequence (Fig. 1). Restriction enzyme
digests of the multiple independent clones of the two large
cDNA clones (Fig. 1C and D) produced expected fragments
as predicted from the genomic sequence (Fig. 2). The viral
RNA is predicted to be composed of 8207 bases with a
structure resembling the C-type M-MLV. The genomic
structure was deduced (Fig. 2) from comparative analysis
with other MLV sequence data using BLASTN (National
Center for Biotechnology Information genetic databases).
The 5-terminal region consists of a 73-nt identical re-
peat (R) region, also found at the 3-terminal region (nt
8135 to 8207). Downstream of the 5R region is the 62-nt
U5 region followed by the primer-binding site (nt 146 to
163), which is complementary to the last 18 nucleotides at
the 3 end of a transfer RNA (tRNA) (Mak and Kleiman,
1997). Sixteen clones were obtained, of which 8 clones had
one PBS sequence (TGGAGGTCCCACCGAGAT) that
would be primed by threonine tRNA and the other 8 (TG-
GAGGCCCCAGCGAGAT) (base changes underscored)
primed by glutamine-2 tRNA (Sprinzl et al., 1989).
Two open-reading-frames (ORF) could be identified by
sequence analysis using the GCG program (Madison, WI).
The first ORF can encode a 536-amino acid (aa) precursor
Gag polypeptide, followed by a read-through of an amber
stop codon to encode a 112-aa putative protease protein and
a 1084-aa polymerase protein. The second ORF indicates a
spliced message of 2910 nt from the 5 splice donor site to
the 3 splice acceptor site and can encode a 644-aa envelope
Fig. 1. Schema for cloning the DG-75 retrovirus. (A) R-U5 region using the tRNA primer-binding site to reverse-transcribe the viral RNA followed by
amplification of the poly(C)-tailed cDNA by PCR. (B) pol region using degenerate pol primers to amplify a random primed viral cDNA. (C) The 5 region
using an oligo(dT)-primed viral cDNA amplified by PCR using primers from the pol region (B) and putative R region (A). (D) 3 region using an
oligo(dT)-primed viral cDNA amplified by PCR using primers from the pol region (B) and putative R region (A). (E) 3 end of the viral genome amplified
by PCR using the 3 RACE technique with a primer from the putative U3 region (D).
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polypeptide. Downstream from the env stop codon is the
337-nt U3 region followed by the R region and a polyade-
nylated tail.
Analysis of viral homology
A search of the current databases, EMBL and GenBank,
using the complete DG-75 nucleotide sequence as query,
showed 92.7% identity with the complete genomic se-
quence from a retrovirus in the genome of the mouse my-
eloma cell line SP2/0-Ag-14 (Accession No. X94150). Ho-
mology searches performed with individual regions of the
DG-75 retrovirus were more informative. The R-U5 and
R-U3 nucleotide sequence showed the highest homology,
98 and 97%, respectively, to a defective murine proviral
sequence, Evi-2 (Accession No. S80082). The nucleotide
sequence of the gag region showed 97% homology to Evi-2.
The nucleotide sequence of the pol region showed an over-
all homology to the Retroviridae complete genome of 94%,
with 95% homology of the initial 5 1490 bases of the pol
region to Moloney MLV (Accession No. AF033811); and
the remaining 1765 bases were 97% homologous to the
truncated pol sequence of Evi-2. The nucleotide sequence of
the env region showed a 98% homology to MLV-NZB-9-1
xenotropic DNA (Accession No. K02730) (Mosier et al.,
1985).
Identification of viral genome
The structure of the viral RNA predicted two viral
mRNA species to be transcribed. The R-U5 clone (Fig. 2)
was therefore used as a riboprobe for Northern blot analysis
since all DG-75-specific viral RNAs should hybridize to this
sequence. The predicted viral structure was confirmed when
an antisense R-U5 riboprobe hybridized to two mRNA
species from the DG-75 sublines UW and KAR (Fig. 3), a
full-length viral mRNA of approximately 8.2 kb and a
putative env mRNA of approximately 2.9 kb. No viral
mRNA was identified in the HAD subline nor did the sense
probe hybridize to any mRNA species (data not shown).
Defective RNA species with large deletions were not de-
tected. As a positive control, a GAPDH probe showed
similar levels of nondegraded mRNA in each lane.
To confirm that the two viral RNA bands were consistent
with their predicted structure, specific probes for the gag,
pol, and env sequences were designed (Fig. 2). The probes
hybridized to the DG-75 (UW) mRNA to identify their
respective viral RNA segments (Fig. 4). All three probes
identified a full-length viral RNA of 8.2 kb, whereas only
the env probe identified the 2.9-kb sequence to confirm the
identity of the envelope mRNA.
Fig. 2. A map of the 8207-base genome of the DG-75 retrovirus, showing the start codon (AUG), termination codon (UAA), amber stop codon (UAG), and
the splice donor (SD) and acceptor (SA) sites with their nucleotide locations. Two open reading frames are predicted, one encoding the Gag and Pol
polyproteins, and the other, a 3-kb spliced mRNA encoding the Env polypeptides. Restriction enzyme sites are indicated by single letters: A, AccI; S, SmaI;
and E, EcoRI. The R-U5 riboprobe (cross-hatched box) and the gag, pol, and env double-stranded DNA probes (stippled box) were used for Northern blot
analyses.
Fig. 3. Northern blot analysis of mRNA isolated from three sublines of
DG-75 cells. (A) The blot was probed with a 32P-labeled antisense ribo-
probe from the R-U5 clone (Fig. 2). A full-length mRNA of approximately
8.2 kb and a spliced 2.9-kb mRNA were found in the KAR and UW
sublines. (B) The blot was stripped and probed with a 32P-labeled DNA
probe for GAPDH to show equal loading of the RNA in each lane.
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Host range and interference assays
The host range of the DG-75 virus was examined by
pseudotype formation. Human TE671 and murine NIH3T3
cells harboring an MLV vector coding for -galactosidase,
that is, TEL and 3T3L cells, respectively, were cocultivated
with DG-75 (KAR) virus-infected cells for 2 weeks. Cell
supernatants were harvested and tested for mobilization of
the MLV vector on TE671 and NIH/3T3 cells. While no
enzymatic activity was recovered from the 3T3L cells, the
TEL cells produced a titer of 105 cfu/ml on TE671 cells.
These results indicated that human cells, but not murine
cells, have a receptor for the DG-75 virus and can support
its replication. The results are consistent with the sequence
data, indicating that the envelope sequence belongs to the
xenotropic class of MLV.
To characterize further the receptor for DG-75 virus, a
cross-interference assay was carried out by challenging cells
chronically infected with xenotropic and amphotropic MLV
with lacZ vectors carrying the DG-75 envelope (Table 1).
The MLV-X virus efficiently blocked infection of the lac-
ZDG-75 virus on TE/MLV-X cells. The infection was
blocked 500-fold when compared to uninfected TE671
cells, whereas no reduction of titer was observed on the
TE/MLV-A cells. In the same experiment, efficient autoint-
erference of MLV-X and MLV-A was shown as TE/
MLV-X and TE/MLV-A blocked lacZMLV-X and lac-
ZMLV-A by 650- and 10,000-fold, respectively. These
results indicate that the DG-75 virus and MLV-X (NZB)
share the same receptor and confirm that DG-75 virus is a
xenotropic MLV.
Further, host-range infectivity experiments showed that
the DG-75 virus was incapable of infecting murine NIH 3T3
and SC-1 fibroblasts, as well as marmoset EBV-transformed
B-cells, B95-8 (data not shown). However, after infection of
the human foreskin fibroblast FS-7 strain and rat sarcoma
XC cells, as well as the DG-75 (HAD) subline, PCR-
amplifiable DG-75 virus sequences were found integrated in
their cellular genomes 21 or 30 days after infection (data not
shown). Unlike classical MLV-X, the DG-75 virus failed
repeatedly to grow in Mv1.Lu mink lung cells. Following
intraperitoneal injection of DG-75 virus into sixteen 3- to
4-week-old male C57BL/6 mice, no hepatosplenomegaly or
lymphodenopathy was noted either in 3 mice sacrificed at 4
months or in the remaining mice at 9 months, all of which
had remained healthy.
Discussion
The DG-75 retrovirus is a replication-competent, murine
leukemia virus variant with an 8207-base genomic RNA.
The full-length genomic RNA encodes a putative 536-aa
precursor Gag polypeptide, followed by a read through of an
amber stop codon to encode a 112-aa putative protease
protein and a 1084-aa polymerase domain. Immunoblot
analysis showed the p30 protein from DG-75 retrovirus to
be immunoreactive with anti-MLV p30 antiserum (Raisch
et al., 1998). The viral env gene, a 2910-base spliced
mRNA, encodes a putative 644-aa Env polypeptide, which
is cleaved to a predicted 70-kDa surface unit (SU) glycop-
rotein and a 15-kDa transmembrane (TM) domain. The
putative aa sequence of the SU is highly homologous to
other xenotropic Env sequences and identical in the variable
regions A and B to the NZB-9-1 retroviral sequence (Fig.
5). Variable region A is considered to be important in
specifying receptor recognition, whereas variable region B
is used for stabilization of the virus to the receptor (Battini
et al., 1992).
Some characteristics of the DG-75 retrovirus distinguish
it from other murine retroviruses. The most common primer
tRNA for murine leukemia viruses is the one for proline
(Harada et al., 1979), although murine retroviral PBS se-
quences have been reported that are complementary to
tRNAs for glutamine, phenylalanine, theronine, and glycine
Table 1
Cross-interference assay to confirm the receptor tropism
of the DG-75 retrovirus
Virus Mean of quadruplicate LacZ pseudotype titers
(colony-forming units/ml)a in the cells indicated
TE671b TE/MLV-Ab TE/MLV-Xb
MLV-A 1.3  107 1.5  103 1.2  107
MLV-X 6.5  105 6.0  105 1.0  103
DG-75 9.3  104 1.2  105 1.9  102
a Standard error of the mean for all titers 15%.
b TE/MLV-A and TE/MLV-X are human rhabdomyosarcoma TE671
cells chronically infected with amphotropic MLV-A 1504 and xenotropic
MLV-X NZB virus strains, respectively.
Fig. 4. Northern blot analysis of mRNA from the DG-75 (UW) cells. Each
probe is a 32P-labeled DNA generated by PCR using primers specifically
designed to amplify a portion of the gag, pol, or env genes (Fig. 2). All
three probes identified a full-length viral mRNA of approximately 8.2 kb,
while only the env probe identified the spliced mRNA of 2.9 kb. A GAPDH
probe was used to show that there was no degraded mRNA in each lane
(data not shown).
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(Colicelli and Goff, 1986; Nikbakht et al., 1985; Policastro
et al., 1989). Sequence analysis indicates that the PBS of
DG-75 virions are complementary to the 3 end of human
tRNAThr and tRNAGln2. The cloning of the PBS for two
tRNA species from the same population of virions is un-
usual. Lund et al. (1993) showed that progeny virions of
cells transfected with an Akv-MLV-based retroviral vector
containing the glutamine-1 tRNA PBS had an equal pro-
portion of tRNAs for glutamine-1 and -2. The identification
of two different PBS sequences, that is, for tRNA primers
for threonine and glutamine-2, in DG-75 virus suggests that
alternative tRNA molecules may also be used in the repli-
cation of this virus.
A coding sequence for the Gag polypeptide is 96%
homologous to a truncated retroviral sequence identified by
its integration in the ecotropic viral integration site-2, Evi-2,
a common integration site involved in murine myeloid leu-
kemogenesis and located within the neurofibromatosis type
1 gene, a tumor suppressor gene (Cho et al., 1995). The
endogenous Evi-2 retroviral sequence contains a complete
ORF for the gag gene and a truncated pol and env gene
bordered by a xenotropic LTR on the 5 end. The truncated
pol and env genes have 97 and 96% homology, respectively,
with the DG-75 retrovirus sequence. The DG-75 R-U5 re-
gion is 98% identical to the same region of the Evi-2
sequence. However, the PBS for DG-75 virus corresponds
to glutamine-2 and threonine tRNA, whereas only threonine
tRNA has been identified for the Evi-2 provirus. The gag
gene for Evi-2 has high homology to the murine immuno-
deficiency (MAIDS) MLV variant, LP-BM5 (Mak and
Kleiman, 1997; Miller et al., 1994), the truncated sequence
of which has a functional gag gene followed by only partial
sequences of the pol and env genes (Cho et al., 1995); to be
infectious, the LP-BM5 truncated virus requires a helper
virus (Chattopadhyay et al., 1991). The truncated genome of
Evi-2 may also require a helper virus to be infectious. Based
on the homology between Evi-2 and the LP-BM5 MAIDS
virus, it is conceivable that DG-75 retrovirus infection may
be able to induce immune suppression in an appropriate line
of feral mice. Further studies are necessary to determine the
pathogenesis of the DG-75 retrovirus, for example, if it
would induce immunodeficiency or produce tumors in feral
mice.
The putative mRNA encoding the env gene of the DG-75
retrovirus is most closely related to the MLV NZB-9-1
xenotropic env mRNA (O’Neill et al., 1985) with a 98%
sequence identity at the nucleotide level. Since the sequence
of only the NZB-9-1 env mRNA has been reported, it is not
possible to know whether the high homology to the env
gene of the DG-75 retrovirus extends into the gag region
and the remaining pol region. The complete proviral se-
quence of the NZB-9-1 retrovirus would be necessary to
determine its relationship to the DG-75 retrovirus genome.
It is of interest that the truncated Evi-2 retroviral sequence
contains a U3-R region and fragments of the pol and env
genes that have nearly identical homology to the NZB-9-1
Fig. 5. Schematic diagram of a MLV gp70 protein with the designation of variable regions A (VRA) and B (VRB) which have been identified as important
regions for the characterization of cellular tropism (Battini et al., 1992). Alignment of the putative amino acid sequence of DG-75 retrovirus for VRA and
VRB with retroviral protein sequences from the following viruses: mlvenvx, xenotropic MLV NZB-9-1 (O’Neill et al., 1985); mcfenvp, polytropic MLV
MCF 247 (Holland et al., 1983); mkvenva, amphotropic MLV 4070A (Ott et al., 1990); and mlvenve, ecotropic Mo-MLV (Shinnick et al., 1981). The
standard one-letter code for amino acids is used: capital letters indicate conserved amino acids, small characters represent variable positions, and dots are
used for proper spacing.
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retroviral sequence and the DG-75 proviral sequence. The
high homology of regions of the exogenous DG-75 retro-
virus and the truncated Evi-2 sequence suggest that the latter
may be a deletion mutant of the former.
The origin of the constitutively produced retrovirus in
the DG-75 KAR or UW sublines is not known. It is clear
that an early passage of these cells, the HAD subline, is free
of retroviruses as determined by Northern (Fig. 3) and
Southern (data not shown) blot analyses, immunoblot, elec-
tron microscopy, and the PCR-based product-enhanced re-
verse transcriptase assay (Raisch et al., 1998). Propagating
human tumor cells in immunodeficient mice has resulted in
infection of the cells with xenotropic murine viruses (Levy,
1973; Todaro et al., 1973); and retroviral contamination has
been reported of the human B-lymphoblastoid cell line,
Ramos, after its passage in nude mice (Kotler et al., 1977).
The investigators who have carried the DG-75 sublines in
their laboratories have indicated that no attempts were made
either to passage the cells in nude mice, to introduce by
transfection a murine leukemia virus infectious clone, or to
infect them otherwise with such viruses.
It is not known whether the DG-75 virus can infect
primary human B-lymphocytes. In view of current efforts to
design better retroviral vectors, especially those based on
murine leukemia virus, further characterization of the cell
tropism of the DG-75 retroviruses may be valuable.
Materials and methods
Cell lines
The EBV-negative human B-lymphoblastoid cell lines
(and their sources) included the three DG-75 cell sublines,
designated UW (B. Sugden, University of Wisconsin, Mad-
ison WI), KAR (G. Klein, Karolinska Institute, Stockholm
Sweden), and HAD (H. Ben-Bassat, Hadassah Medical
Center, Jerusalem Israel). The EBV-positive marmoset B-
cell B95-8 cell line was provided by G. Miller (Yale Uni-
versity, New Haven, CT). These cell lines were maintained
in RPMI 1640 medium supplemented with 10% heat-inac-
tivated fetal bovine serum (FBS), glutamine, and antibiot-
ics. The human foreskin cell strain FS-7 (B. Brown, Chil-
dren’s Hospital, Milwaukee, WI) and NIH/3T3 line (CRL-
1658, ATCC) were grown in Dulbecco’s modified Eagle’s
medium (DMEM) with 10% FBS, as were the SC-1 mouse
fibroblasts, the Mv1.Lu mink lung cells, and XC rat sarcoma
cells (all from R. Risser, University of Wisconsin).
Viral interference assay utilized human rhabdomyosar-
coma TE671 cells (CRL8805) and murine NIH/3T3 cells
and their derivatives (Takeuchi et al., 1994), which were
cultured in DMEM supplemented with 10% heat-inacti-
vated fetal bovine serum, glutamine, and antibiotics. TE/
MLV-A and TE/MLV-X are TE671 cells chronically in-
fected with MLV-A 1504 and MLV-X NZB virus strains,
respectively. TELCeB6/AF-7 cells are packaging cells pro-
ducing helper-free LacZ(MLV-A) pseudotypes. TEL and
3T3L cells are TE671 and NIH/3T3 cells, respectively,
harboring the MFGnlslacZ retroviral vector. TEL/MLV-X
are TEL cells infected with MLV-X NZB, which thereby
produce LacZ (MLV-X) pseudotypes as well as replication-
competent MLV-X.
Isolation of retroviral RNA
Virus isolation and purification of the DG-75 (UW) ret-
rovirus has been described previously (Raisch et al., 1998).
Briefly, the filtered supernatant was precipitated with poly-
ethylene glycol, and the virus was isolated in a sucrose
step-gradient and then further purified through a continuous
sucrose gradient. Reverse transcriptase-positive fractions
were collected, and the virus was concentrated by ultracen-
trifugation. The virus pellet was suspended in 100 l TEN
(0.01 M Tris–HCl, pH 7.3; 0.001 M EDTA, 0.050 M NaCl)
buffer, denatured in 4 M guanidine thiocyanate (500 l) for
5 min at room temperature (RT), and then mixed with an
equal volume of phenol:chloroform:isoamyl alcohol (25:24:
1). After 10 min at RT, the phases were separated at 15,000
g for 15 min. The aqueous phase was collected, and the
organic phase was back-extracted with DEPC-treated H2O.
The two aqueous phases were pooled and extracted once
with chloroform:isoamyl alcohol (24:1). The aqueous phase
was collected and precipitated with 20 g glycogen, 0.1 vol
of 3 M sodium acetate, pH 5.0, and 2.5 vol of 100% ethanol
for 18 h at 20°C. The RNA was pelleted at 15,000 g for
15 min at 4°C, washed once with ice-cold 70% ethanol, and
suspended in DEPC–H2O. The RNA was quantitated spec-
trophotometrically at 260 nm.
Cloning the R-U5 region
The R-U5 cloning protocol of Lo¨wer et al., (1993) was
used with minor modifications (see Fig. 1A). In a 10-l
reaction mixture, 80 ng of purified viral RNA was mixed
with 1 RT buffer (Gibco BRL, Gaithersburg, MD); 1 mM
DTT; 10 ng RNase-free BSA (Amersham Pharmacia Bio-
tech, Piscataway, NJ); 1 mM each dTTP, dATP, dGTP; 1 U
RNase inhibitor (Ambion Inc., Austin, TX); 2 U M-MLV
RT (Gibco BRL); 30 Ci [32P]dCTP (3000 Ci/mmol, NEN,
Boston, MA); and 300 ng PBS primer containing an EcoRI
site restriction enzyme on the 5 end. Twelve PBS primers
were used and are presented in the 5 to 3 direction: arg1,
CGT AGA ATT CCT CCT GGC TGG CTC ACC A; arg2,
CGT AGA ATT CGT CCC TTC GTG GTC GCC A; gly,
CGT AGA ATT CTC CCC GGC CAA TGC ACC A; gln,
CGT AGA ATT CAT CTC AGT GGA ACC TCC A; his,
CGT AGA ATT CAT CTG AGT CAC AGC ACC A; ile,
CGT AGA ATT CTC CCT GTA TGG GCC ACC A; phe,
CGT AGA ATT CTC CCG GGT TTC GGC ACC A; glu,
CGT AGA ATT CTT CCT GGC CAG GGA ACC A; pro,
CGT AGA ATT CAT CCC GGA CGA GCC CCC A; trp,
CGT AGA ATT CAT CAC GTC GGG GTC ACC A; lys1,2,
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CGT AGA ATT CGC CCC ACG TTG GGC GCC A; and
lys3, CGT AGA ATT CTC CCT GTT CGG GCG CCA.
The reaction mixture was incubated at 37°C for 40 min,
supplemented with 1 l dCTP (10 mM), and incubated for
an additional 20 min. The reaction was stopped by adding 5
l of stop solution (98% formamide, 10 mM EDTA,
0.025% bromphenol blue) and heated to 95°C for 3 min.
The reaction products were separated in an 8 M urea:8%
polyacrylamide sequencing gel. The wet gel was wrapped
with plastic wrap and exposed to X-ray film to identify the
single-stranded cDNA bands. The cDNA bands were ex-
cised from the gel and extracted in extraction buffer (0.5 M
ammonium acetate; 10 mM magnesium acetate; 1 mM
EDTA, pH 8.0; 0.1% SDS at 37°C for 4–6 h on a rotating
wheel (Sambrook et al., 1989)). Any insoluble material was
removed by centrifugation at 15,000 g for 15 min. The
soluble phase was collected, and extraction buffer was
added to the insoluble pellet for an additional 2 h at 37°C.
The soluble phase was separated from the insoluble material
and pooled with the first soluble phase. The cDNA was
precipitated with 20 g glycogen; 0.1 vol of 3 M sodium
acetate, pH 5.2; and 2.2 vol of 100% ethanol for 18 h at
20°C.
The single-stranded cDNA was homopolymer-tailed
with dCTP following the manufacturer’s protocol from the
DNA Tailing kit (Boehringer Mannheim, Indianapolis, IN).
The poly(dC)-tailed cDNA was amplified by PCR using 50
pmol of each primer, a poly(dG) primer containing either a
BamHI (5-TCT AGA GGA TCC (G)12-3) or a HindIII
(5-GAA TAC AAG CTT (G)12-3) restriction enzyme site,
and the corresponding tRNA PBS primer containing an
EcoRI restriction enzyme site. After amplification for 35
cycles at 94°C (30 s), 55°C (1 min), 72°C and (1 min), the
purity of the PCR product was verified by agarose gel
electrophoresis and then concentrated by ethanol precipita-
tion (Sambrook et al., 1989). The amplified cDNA was
suspended in H2O and digested with the appropriate com-
bination of restriction enzymes. The restriction enzyme-cut
PCR products were separated in low-melting-temperature
(LMT) agarose gel (Gibco BRL) and isolated by gel extrac-
tion (Bio101, Vista, CA). The amplified cDNA was quan-
titated spectrophotometrically and then ligated into restric-
tion enzyme-cut pGEM3Z (Promega, Madison, WI).
Competent JM109 cells (Promega) were transformed ac-
cording to the manufacturer’s protocol.
Amplification of the conserved pol region
Purified DG-75 viral RNA (1 g) was reverse tran-
scribed with random hexamer primers (Sambrook et al.,
1989). The cDNA was amplified by PCR using degenerate
pol primers as described by Shih et al., 1989 (see Fig. 1B).
Briefly, the degenerate PCR primers containing an EcoRI
restriction enzyme site presented in the 5–3 direction, gs,
CGC GGA TCC TGG AAA GTG (C/T)T(A/G) CC(A/C)
CA(A/G) GG; and gen, CGC CCA TCC GG(A/C) GGC
CAG CAG (C/G)A(G/T) GTC ATC CA(C/T) CTA, were
used to amplify the cDNA by standard PCR techniques of
three cycles at 94°C (30 s), 37°C (30 s), and 72°C 1 min
followed by 35 cycles at 94°C (30 s), 55°C (30 s), and 72°C
1 min. The 135-bp pol product was agarose gel-purified and
ligated into the pGEM-T vector (Promega), which was used
to transform competent JM109 cells.
Amplification and cloning of the 5 region
An internal primer from the 135-bp pol region was syn-
thesized to prime toward the 5 end, DG-75POLr (5-GTG
GGA CTG TTT TTG AAA CCC TGT-3). A second primer
was synthesized from the putative R region of the R-U5
clone to prime toward the 3 end, DG-75LTRf (5-CCG
TGT CCC AAT AAA GCC TC-3). Amplification of the 5
region using the expanded long template PCR kit (Boehr-
inger Mannheim) was performed on oligo (dT)-primed viral
RNA (see Fig. 1C). Briefly, DG-75 viral RNA (1 g) was
reverse-transcribed with oligo (dT)-primers using Super-
Script RT (Gibco BRI). A 50-l PCR mixture consisted of
1 PCR buffer containing 1.75 mM MgCl2, 350 M each
dNTP, 360 pM DG-750POLr primer, 360 pM DG-75LTRf
primer, 0.75 l of enzyme, and 100 ng of viral cDNA. The
reaction mixture was denatured for 2 min at 90°C followed
by 30 cycles of 94 °C for 15 s, 60°C for 30 s, and 68°C for
6 min, with 20 s added to each elongation step for the final
20 cycles. The PCR-generated fragment was agarose gel-
purified, tailed with dATP using Taq DNA polymerase, and
ligated into pGEM-T vector to transform competent DH-5
alpha cells (Gibco BRL).
Amplification and cloning the 3 end
An internal primer from the 135-bp pol region was syn-
thesized to prime toward the 3 end, DG-75POLf (5-ACA
GGG TTT CAA AAA CAG TCC CAC-3). A second
primer was synthesized from the putative R region of the
R-U5 clone to prime toward the 5 end, DG-75LTRr (5-
ATC AGC AAG AGG CTT TAT TGG GAA C-3). Am-
plification and cloning of the 3 region was performed on
oligo (dT)-primed viral RNA as described for the amplifi-
cation of the 5 region (see Fig. 1D). The PCR-generated
fragment was agarose gel-purified, tailed with dATP using
Taq DNA polymerase, and then ligated into pGEM-T vector
followed by transformation of competent DH-5 alpha cells.
A 3 RACE kit (Boehringer Mannheim) was used to
clone the 3 end of the viral RNA. Oligo(dT)-primed viral
RNA was reverse-transcribed as described above and am-
plified by PCR with the oligo(dT)-abridged universal adap-
tor primer and a primer from the putative U3 region, 4793F
(5-CAG TTA CAA ATC AAG GCC G-3). After 35 cycles
at 94°C (30 s), 55°C (1 min), 72°C and (1 min), the PCR
fragment was separated by agarose gel electrophoresis, pu-
rified, and ligated into pGEM-T vector followed by trans-
formation of competent DH-5 cells.
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Sequencing DG-75 and analysis of retroviral clones
Plasmid DNA was isolated from positive transformants
using the WIZARD plasmid DNA isolation kit (Promega)
and sequenced in both directions using the Pharmacia ALF
system. Initially, T7, SP6, M13 forward, or M13 reverse
fluorescently labeled primers were used to generate se-
quence data. Fluorescently labeled sequencing primers
(Operon, Alameda, CA) designed from the sequence data
were used to obtain overlapping sequence data in both
directions for each clone. The data were analyzed and a
consensus sequence identified using the GCG program
(Madison, WI).
Isolation and analysis of cellular mRNA
Polyadenylated RNA from the DG-75-UW, KAR, and
HAD cell sublines was isolated using oligo(dT)–cellulose
columns according to the manufacturer’s protocol for the
poly(A) Pure Kit (Ambion, Inc.). Five micrograms of poly-
adenylated RNA was separated using a standard 1% agarose
gel with 0.24 M formaldehyde (Sambrook et al., 1989). The
RNA was transferred to a nylon membrane (Bio-Rad) ac-
cording to Beckers et al. (1994). Briefly, the gel was soaked
two times for 5 min in DEPC-treated H2O. The RNA was
denatured in the gel for 30 min using 0.05 N NaOH and then
equilibrated for 30 min in 20 SSC buffer. The RNA was
transferred to a nylon membrane by capillary elution in 20
SSC buffer for 24 h. The RNA was fixed to the membrane
in 0.05 N NaOH for 5 min and washed in 2 SSC for 2 min.
The blot was blocked in prehybridization buffer (5 SSPE,
5 Denhardt’s, 0.5% SDS, 10 g/ml denatured salmon
sperm DNA) for 2 h.
The R-U5 clone (Fig. 1A) was used to synthesize 32P-
labeled riboprobes using MAXIscript SP6/T7 Kit (Ambion)
(Fig. 2). Hybridization was performed at 60°C for 20 h in
prehybridization buffer. Blots were washed under stringent
conditions: 2 SSC, 0.1% SDS for 15 min at 37°C; 2 SSC,
0.1% SDS twice for 15 min each at 65°C, 1 SSC, 0.1% SDS
twice for 15 min each at 65°C; 0.1 SSC, 0.1% SDS for 15
min at 65°C. The blots were analyzed by autoradiography.
Radiolabeled DNA probes were generated by PCR for
the gag (nts 1082–1520), pol (nts 3984–4689), and env (nts
6150–6686) regions (Fig. 2). The probes were separated by
LMT agarose gel electrophoresis, extracted, and then
melted at 65°C in hybridization buffer (500 mM NaHPO4,
pH 7.2, 7% SDS). Hybridization to DG-75 (UW) mRNA
was carried out at 65°C for 18 h followed by two washes in
40 mM NaHPO4, pH 7.2, 5% SDS, and two washes in 40
mM NaHPO4, pH 7.2, 1% SDS, all at 65°C for 30 min. The
blots were analyzed by autoradiography.
Interference assay
TEL and 3T3L cells were cocultivated with DG-75
(KAR) virus-infected cells for 2 weeks. LacZ pseudotypes
were harvested in DMEM–10% FBS, filtered through a
0.45-m filter, and used immediately for LacZ infection as-
says. Harvested virus was diluted with DMEM–10% FBS
containing 8 g/ml of polybrene and plated on the assay cells
in 24-well plates. After 4 h of infection, virus was removed and
the cells were cultivated in growth medium. Two days after
infection, the cells were stained with 5-bromo-4-chloro-3-in-
dolyl--D galactopyranoside (X-Gal) in situ. LacZ-positive
colonies were counted as previously described (Cosset et al.,
1995; Tailor et al., 1993; Takeuchi et al., 1994).
Infectivity experiments
Virus-containing DG-75 (UW) cell-culture supernatant,
clarified by low-speed centrifugation and passed through a
0.2-m filter, was added with 2 g/ml polybrene directly to
70% confluent cell monolayers or to 1 106 cells/ml in
suspension. Suspension cultures were incubated at 36°C for
2 h and then diluted 1:2 with culture medium and incubated
at 36°C for an additional 16 h. The medium of suspension
and monolayer cultures was replaced after 18 h at 36°C with
fresh medium and again subsequently as indicated. At 10, 21,
and 30 days after infection, supernatant fluids were assayed for
reverse transcriptase as previously described (Raisch et al.,
1998), and genomic DNA from cell pellets was analyzed for
integrated virus by nested PCR of the env region.
Nucleotide sequence accession number
The complete nucleotide sequence of the DG-75 MLV
variant has been entered into the GenBank nucleotide se-
quence database (Accession No. AF221065).
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